The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-({(2R)-1-[4-(3-Buten-1-ylamino)-6-({[2-(2-thienyl)-1,3-thiazol-4-yl]methyl}amino)-1,3,5-triazin-2-yl]-2-pyrrolidinyl}-methyl)-4-propylbenzenesulfonamide ID: ALA2164121
PubChem CID: 66560021
Max Phase: Preclinical
Molecular Formula: C29H36N8O2S3
Molecular Weight: 624.86
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C=CCCNc1nc(NCc2csc(-c3cccs3)n2)nc(N2CCC[C@@H]2CNS(=O)(=O)c2ccc(CCC)cc2)n1
Standard InChI: InChI=1S/C29H36N8O2S3/c1-3-5-15-30-27-34-28(31-18-22-20-41-26(33-22)25-10-7-17-40-25)36-29(35-27)37-16-6-9-23(37)19-32-42(38,39)24-13-11-21(8-4-2)12-14-24/h3,7,10-14,17,20,23,32H,1,4-6,8-9,15-16,18-19H2,2H3,(H2,30,31,34,35,36)/t23-/m1/s1
Standard InChI Key: IIXODPXDUIIVAF-HSZRJFAPSA-N
Molfile:
RDKit 2D
42 46 0 0 0 0 0 0 0 0999 V2000
27.5795 -5.5188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0349 -7.0678 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
29.5084 -6.4066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0209 -5.7435 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2439 -6.0005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2500 -6.8210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3330 -6.4014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8205 -7.0604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6016 -6.8034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5964 -5.9788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8115 -5.7320 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
25.4739 -3.4418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2021 -3.0555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8993 -3.4957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7452 -5.6764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3283 -4.9686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5078 -4.9747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1001 -5.6895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5171 -6.3982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3417 -6.3912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5649 -5.6662 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.9848 -4.9603 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8068 -4.9571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0174 -5.8847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2252 -5.6680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7728 -6.3483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2852 -6.9918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0520 -6.7029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7453 -4.6612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.7326 -5.4840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4378 -5.9046 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.1574 -5.5021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1663 -4.6810 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.4594 -4.2608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8626 -5.9227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3502 -6.4550 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.2747 -6.0712 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6261 -3.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3219 -3.5495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2829 -5.6951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8695 -4.9902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0524 -4.9957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
2 6 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
7 11 1 0
3 7 1 0
1 5 1 0
12 13 1 0
13 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
21 22 1 0
15 21 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
24 28 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
29 34 2 0
34 12 1 0
32 35 1 0
24 30 1 0
25 23 1 6
22 23 1 0
21 36 2 0
21 37 2 0
14 38 1 0
38 39 2 0
35 1 1 0
18 40 1 0
40 41 1 0
41 42 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 624.86Molecular Weight (Monoisotopic): 624.2123AlogP: 5.56#Rotatable Bonds: 15Polar Surface Area: 125.03Molecular Species: BASEHBA: 11HBD: 3#RO5 Violations: 3HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.39CX Basic pKa: 8.77CX LogP: 6.73CX LogD: 5.43Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.12Np Likeness Score: -1.56
References 1. Deng H, O'Keefe H, Davie CP, Lind KE, Acharya RA, Franklin GJ, Larkin J, Matico R, Neeb M, Thompson MM, Lohr T, Gross JW, Centrella PA, O'Donovan GK, Bedard KL, van Vloten K, Mataruse S, Skinner SR, Belyanskaya SL, Carpenter TY, Shearer TW, Clark MA, Cuozzo JW, Arico-Muendel CC, Morgan BA.. (2012) Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT)., 55 (16): [PMID:22891645 ] [10.1021/jm300449x ]